Robert W. Baird reiterated their buy rating on shares of Tenet Healthcare Corporation (NYSE:THC) in a research note published on Thursday morning. Robert W. Baird currently has a $23.00 target price on the stock.

Other research analysts have also recently issued research reports about the stock. Jefferies Group LLC reiterated a buy rating and set a $26.00 price target (down previously from $28.00) on shares of Tenet Healthcare Corporation in a report on Saturday, April 29th. Zacks Investment Research upgraded shares of Tenet Healthcare Corporation from a hold rating to a strong-buy rating and set a $21.00 price target for the company in a report on Monday, July 10th. Wells Fargo & Company upgraded shares of Tenet Healthcare Corporation from a market perform rating to an outperform rating and set a $22.00 price target for the company in a report on Tuesday, June 6th. Citigroup Inc. reiterated a neutral rating and set a $16.00 price target (down previously from $20.00) on shares of Tenet Healthcare Corporation in a report on Thursday, August 10th. Finally, Leerink Swann upgraded shares of Tenet Healthcare Corporation from a market perform rating to an outperform rating and set a $27.00 price target for the company in a report on Tuesday, June 6th. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of Hold and a consensus price target of $21.43.

Tenet Healthcare Corporation (THC) opened at 16.50 on Thursday. The stock’s 50 day moving average price is $17.03 and its 200-day moving average price is $17.80. The company’s market capitalization is $1.66 billion. Tenet Healthcare Corporation has a 52 week low of $12.54 and a 52 week high of $24.86.

Tenet Healthcare Corporation (NYSE:THC) last posted its quarterly earnings results on Monday, August 7th. The company reported ($0.17) EPS for the quarter, hitting the consensus estimate of ($0.17). Tenet Healthcare Corporation had a negative net margin of 0.97% and a negative return on equity of 2.00%. The company had revenue of $14.80 billion during the quarter, compared to analysts’ expectations of $4.90 billion. During the same quarter in the previous year, the business posted $0.38 EPS. The firm’s revenue was up 204.1% on a year-over-year basis. On average, equities research analysts predict that Tenet Healthcare Corporation will post $0.82 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Tenet Healthcare Corporation (THC) Earns “Buy” Rating from Robert W. Baird” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/28/tenet-healthcare-corporation-thc-earns-buy-rating-from-robert-w-baird.html.

A number of hedge funds have recently modified their holdings of the company. Private Management Group Inc. boosted its stake in shares of Tenet Healthcare Corporation by 0.3% in the first quarter. Private Management Group Inc. now owns 804,532 shares of the company’s stock worth $14,248,000 after buying an additional 2,379 shares in the last quarter. MARSHALL WACE ASIA Ltd acquired a new stake in shares of Tenet Healthcare Corporation during the first quarter worth $3,634,000. North Tide Capital LLC acquired a new stake in shares of Tenet Healthcare Corporation during the first quarter worth $35,420,000. Bank of Montreal Can boosted its stake in shares of Tenet Healthcare Corporation by 119.3% in the first quarter. Bank of Montreal Can now owns 12,667 shares of the company’s stock worth $223,000 after buying an additional 6,892 shares in the last quarter. Finally, State Street Corp boosted its stake in shares of Tenet Healthcare Corporation by 1.2% in the first quarter. State Street Corp now owns 2,333,013 shares of the company’s stock worth $41,316,000 after buying an additional 27,898 shares in the last quarter.

About Tenet Healthcare Corporation

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Analyst Recommendations for Tenet Healthcare Corporation (NYSE:THC)

Receive News & Stock Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related stocks with our FREE daily email newsletter.